CHICAGO (Reuters) - Doctors should prescribe the lowest doses of Celebrex possible in patients at high risk of heart problems, researchers who did a combined analysis of six studies of the Pfizer Inc ...
Machine Learning Model Integrating Computed Tomography Image–Derived Radiomics and Circulating miRNAs to Predict Residual Teratoma in Metastatic Nonseminoma Testicular Cancer Capecitabine, an oral ...
WASHINGTON (Reuters) - U.S. drug reviewers have questioned Pfizer Inc.'s data showing the pain reliever Celebrex was as effective as an older drug in treating juvenile rheumatoid arthritis, a summary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results